Welcome to the repository for all things DNAnexus. Sort through Case Studies, Webinars, White Papers, and Videos by their associated DNAnexus product and key topics for a deeper dive into the power our platform and expertise.
Your team members contribute the most when they’re focused on science, not when they’re spending valuable time fixing and optimizing your bioinformatics system.
Large-scale omics datasets are revolutionizing how pharmaceutical companies identify targets for therapeutic development, and have become one of the main paths in accelerating precision medicine.
A bioinformatics solution is the backbone of any successful precision medicine initiative.
Do you have the right informatics strategy to get to insights quickly while working with the UK Biobank (UKB) dataset?
Today’s genomics landscape is rapidly evolving with the accelerated adoption of multi-omics by biopharma organizations, clinical diagnostics companies, and healthcare systems.
NGS data analysis management systems are the backbone of your dry lab, providing vital functionality for day-to-day workings of your business delivery.
While modern-day drug discovery lacks the drama of Greek mythology, we are still faced with the odyssey of how to deliver on the promise of genomics-based precision medicine.
The promise of precision medicine and better patient outcomes is here, through the utilization and application of genomic data in biomarker discovery and clinical research.
Learn why the FDA, top pharmaceutical companies, global diagnostic test providers, genome centers and sequencing service providers have trusted DNAnexus to support their global genomics programs.
You’ve jumped ahead of the curve, leveraging next-generation sequencing (NGS) to advance precision medicine for better patient care, and you are now experiencing an explosion of demand.
DNAnexus Platform enables researchers and clinicians to focus on their genomic analyses while complying with regulations, laws and industry expectations for security and privacy.
The underlying infrastructure that DNAnexus provides, allows us to focus on our core competencies of R&D and patient care.
There is no way that the level of data analysis and data delivery that need to happen for drug development research would be possible without cloud computing. DNAnexus has been a huge enabler of the things that we do at the Regeneron Genetics Center.
Jeffrey Reid, Chief Data Ofﬁcer
Regeneron Genetics Center
Collaboration is vital to advancing scientiﬁc discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward ﬁnding cures for pediatric cancer and other life-threatening diseases.
James R. Downing, President & CEO
St. Judes Children’s Research Hospital